ALS-08

ALS-08 Uses, Dosage, Side Effects, Food Interaction and all others data.

ALS-08 is a proprietary creatine-derivative that is being developed as a potential therapeutic for amyotrophic lateral sclerosis (ALS). It is being developed by Avicena Group, Inc.

In preclinical models, ALS-08 demonstrated significant neuro-protective effects that have led to increased survival rate, improved motor performance and delayed onset of the disease. It is being tested in combination with two therapies, celecoxib and minocycline, for the treatment of ALS.

Table Of contents

• ALS-08
• Uses
• Dosage
• Side Effect
• Precautions
• Interactions
• Uses during Pregnancy
• Uses during Breastfeeding
• Accute Overdose
• Food Interaction
• Half Life
• Volume of Distribution
• Clearance
• Interaction With other Medicine
• Contradiction
• Storage

Trade Name	ALS-08
Generic	ALS-08
Type
Groups	Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated:	September 19, 2023 at 7:00 am

Uses

Investigated for use/treatment in amyotrophic lateral sclerosis (ALS).

Innovators Monograph

You find simplified version here ALS-08